Bringing clarity to the previously opaque infusion center landscape

Infusion centers are a vital part of the U.S. healthcare system, delivering life-sustaining therapies to patients across a wide range of conditions—from oncology and neurology to immunology and rheumatology. As the demand for infusion therapy grows, so does the need for better visibility into where and how infusion services are delivered.

At McKesson Compile, we’re excited to announce a new enhancement to Provider 360 ReadyData™: a comprehensive collection of key data attributes that profile infusion center activity, bringing much-needed clarity to this fragmented and opaque segment of healthcare landscape.

Understanding the Infusion Therapy Landscape

Infusion therapy plays a critical role in treating a wide range of conditions, primarily chronic and complex diseases. Common examples of infusion therapy include chemotherapy, cancer immunotherapy, antibiotics, biologics, and immune globulins. As the U.S. population ages and the prevalence of chronic diseases rises—among both older adults and younger patients—demand will continue to grow.

This demand is further fueled by the increasing number of FDA-approved infusible and specialty drugs, which have surged from just 9 in 2016 to 137 in 2024. This growth of treatments requiring delivery through a needle or catheter by health care professionals reinforces the importance of infusion services.

Infusion therapy can be delivered across a variety of care settings, including:

• Hospitals – Traditional care setting for infusion therapy, provided as either inpatient or outpatient care.
• Physician Office Infusion Centers (OICs) – Facilities owned and managed by the physician practice or third-party provider that are connected to or located near a physician office.
• Ambulatory Infusion Centers (AICs) – Standalone facilities that offer flexible hours and are designed for patient comfort, which are able to drive more patient throughput and operate at a lower cost. Typically, AICs are staffed with trained infusion nurses, pharmacists, and care coordinators.
• Home-based care – Infusion therapy administered by trained nurses in the patient’s home.
  
  

As the infusion landscape continually expands, there has been a significant and ongoing shift in where infusion therapy is delivered. Care is moving away from traditional hospital settings and into more convenient outpatient and home-based environments. This shift is driven by patient preference for comfort, accessibility, and flexibility—especially among older adults with limited mobility—and by the healthcare system’s need to improve efficiency and reduce costs.

Outpatient options like AICs offer multiple benefits, including increased adherence, reduced hospital stays, and higher patient satisfaction. However, the outpatient infusion therapy landscape remains highly fragmented, making it difficult to identify and track these critical centers.

Why Visibility Matters

Despite their growing importance, infusion centers have remained difficult to track. Many are embedded within larger health systems or physician practices, making them hard to isolate in traditional datasets. This lack of transparency hinders timely drug distribution, resource allocation, and ultimately, patient care.

Introducing the Infusion Center feature in Provider 360 ReadyData

To address this gap, we’ve introduced a new infusion center feature in Provider 360 ReadyData. This enhancement delivers unprecedented visibility into over 8,500 outpatient infusion centers across the U.S.

Key information for each infusion center in the dataset include:

• Center type
• Center specialty
• Number of infusion chairs
• Available medications

While no single source has historically captured the full infusion center landscape, our benchmark analysis—based on publicly available data from major infusion center chains—shows that Provider 360 ReadyData achieves near-complete coverage of these networks.

With this new dataset, users are empowered to:

• Prioritize outreach to high-volume infusion centers for targeted therapies
• Track therapy adoption and patient outcomes across diverse care settings
• Forecast drug demand and optimize distribution based on center capacity
• Monitor competitor drug activity at key infusion locations
  
  

This rollout marks a significant step forward in our mission to help empower biopharma companies with enhanced strategic insights by illuminating a previously opaque landscape.

Explore Provider 360 ReadyData Today!

Discover how our new features can transform your understanding of the infusion therapy landscape. Contact us to see the difference for yourself.